Introduction: Pigmented hypertrichosis with insulin-dependent diabetes mellitus (PHID) syndrome is a rare disease, and part of the cluster histiocytosis-lymphadenopathy plus syndrome (H syndrome), which is associated with mutations in the SLC29A3 gene. Patients with PHID show clinical features of H syndrome but also have insulin-dependent diabetes mellitus. The PHID has previously been described as predominantly in absence of pancreatic autoantibodies. Case Series Presentation: Through an open call in two international diabetes registers, clinical and genetic characteristics of 7 PHID patients in 6 treatment centres were collected after informed consent. All of them had consanguinity in their families, and their origins were located in North-African and Middle Eastern regions. Four out of 7 patients had at least one positive pancreatic autoantibody. Discussion and Conclusion: Our case series reveals that PHID exhibits a wide range of clinical symptoms and signs. When consanguinity is present in a patient with newly diagnosed diabetes, and/or if other atypical symptoms such as dysmorphic features, skin lesions, haematological abnormalities, and developmental delay are present, threshold for genetic analysis should be low. Moreover, the presence of autoantibodies should not withhold genetic testing as our case series contradicts the previous observation of predominant autoantibody absence in PHID.

1.
Prendiville
J
,
Rogers
M
,
Kan
A
,
de Castro
F
,
Wong
M
,
Junker
A
, et al
.
Pigmented hypertrichotic dermatosis and insulin dependent diabetes, manifestations of a unique genetic disorder
.
Pediatr Dermatol
.
2007
;
24
(
2
):
101
7
.
2.
Hussain
K
,
Padidela
R
,
Kapoor
RR
,
James
C
,
Banerjee
K
,
Harper
J
, et al
.
Diabetes mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation, and chronic inflammation. Confirmation of a syndrome
.
Pediatr Diabetes
.
2009
;
10
(
3
):
193
7
.
3.
Baldwin
SA
,
Yao
SY
,
Hyde
RJ
,
Ng
AM
,
Foppolo
S
,
Barnes
K
, et al
.
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes
.
J Biol Chem
.
2005
;
280
(
16
):
15880
7
.
4.
Elwi
AN
,
Damaraju
VL
,
Baldwin
SA
,
Young
JD
,
Sawyer
MB
,
Cass
CE
.
Renal nucleoside transporters: physiological and clinical implications
.
Biochem Cell Biol
.
2006
;
84
(
6
):
844
58
.
5.
Senniappan
S
,
Hughes
M
,
Shah
P
,
Shah
V
,
Kaski
JP
,
Brogan
P
, et al
.
Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome
.
J Peiatr Endocrinol Metab
.
2013
;
26
(
9–10
):
877
82
.
6.
Rafiq
NK
,
Hussain
K
,
Brogan
PA
.
Tocilizumab for the treatment of SLC29A3 mutation positive PHID syndrome
.
Pediatrics
.
2017
;
140
(
5
):
e20163148
.
7.
Hsu
CL
,
Lin
W
,
Seshasayee
D
,
Chen
YH
,
Ding
X
,
Lin
Z
, et al
.
Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis
.
Science
.
2012
;
335
(
6064
):
89
92
.
8.
Cliffe
ST
,
Kramer
JM
,
Hussain
K
,
Robben
JH
,
de Jong
EK
,
de Brouwer
AP
, et al
.
SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway
.
Hum Mol Genet
.
2009
;
18
(
12
):
2257
65
.
9.
Novak
I
,
Morgan
C
.
High-risk follow-up: early intervention and rehabilitation
.
Handb Clin Neurol
.
2019
;
162
:
483
510
.
10.
Nihtyanova
SI
,
Denton
CP
.
Current approaches to the management of early active diffuse scleroderma skin disease
.
Rheum Dis Clin North Am
.
2008
;
34
(
1
):
161
79
.
You do not currently have access to this content.